Louise Callesen

PhD fellow in clinical oncology @oncaarhus | Researches colorectal cancer

[DCCC @DCCCcancer]

Nyt ctDNA-RECIST Netværk sætter sig i spidsen for at lede et potentielt paradigmeskifte inden for onkologisk praksis. Læs mere om netværket, der ledes af @GarmSpindler på DCCC’s hjemmeside:
https://t.co/4NX1R1rRsn #SamarbejdeOmKræft #ctDNA

[Therapeutic Advances in Medical Oncology @TAMedOncol]

🔬 Explore our completed Special Collection on #LiquidBiopsy in #GastrointestinalCancers, featuring in-depth research on #ctDNA and #CTCs. Edited by @jonathanloree, Dr. Dirk Arnold, and Dr. Liang Qiao, these studies provide insights for #PrecisionOncology

https://t.co/xGE5THw3mi

[Louise Callesen @L_Callesen]

ctDNA RECIST criteria
https://t.co/QMRCfEN7xo

[Louise Callesen @L_Callesen]

Poster presentation at #ESMO2024 !

🧬Early ctDNA dynamics during systemic treatment is a strong prognostic marker in mCRC.
💡 An update of the systematic review and meta-analyses from 2022
💻 https://t.co/viqLTpsrkb

@GarmSpindler @myESMO

[Louise Callesen @L_Callesen]

➡ Next - Prospective clinical trials to evaluate how ctDNA can assist or even replace radiological evaluations - this is the focus of the #ctDNA_RECIST program led by my mentor @GarmSpindler

[Jonas Busk Holm @jonasbh93]

Last week my smart and very hardworking office buddy and dear friend defended her thesis🇩🇰🥳🎉. Everyone in the research department are going to miss this one an awful lot 🥲 Congratulations Marie, you are the best 🏅
@oncaarhus @MarieTvilum

[Louise Callesen @L_Callesen]

PUBLISHED in @actaoncol: ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study

#ctDNA🧬, #liquidbiopsies🩸, #clinicaltrials 🔬

https://t.co/lgb1djd67H

@GarmSpindler

[Department of Oncology, Aarhus University Hospital @oncaarhus]

Excellent PhD presentation, discussion, defense and dialogue @L_Callesen 👊👏🌟
@HealthAarhusUni @AUHdk

[Louise Callesen @L_Callesen]

A privilege on behalf of the study group to present the results from the interim feasibility analyses of the OPTIMISE study at #WCGIC2023. Looking forward to further discussion at the poster session Saturday🧬

🩸ctDNA-guided treatment in oligometastatic CRC

[Louise Callesen @L_Callesen]

Inspiring days in beautiful Hamborg. I look forward to visiting Nice.

#ISMRC2023 #ctdna🧬 #liquidbiopsy🩸

[Louise Callesen @L_Callesen]

Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors – can we RECIST? Focus on colorectal cancer - Karen-Lise Garm Spindler, Anders Jakobsen, 2023 https://t.co/HJ0NFv6jMa

@GarmLise

[Louise Callesen @L_Callesen]

#ctDNA_RECIST

[Arndt Vogel @ArndtVogel]

🔥ctDNA-Response evaluation criteria in solid tumors- a new measure in medical oncology
@OncologyAdvance
https://t.co/Tc2ySVsbDA
👏Interesting proposal for a response classification based on ct DNA measurements
👉We need prospective evaluation...
@myESMO @OncoAlert

[Louise Callesen @L_Callesen]

Time for a lead-time definition?

#ColorectalCancer #ctdna🧬 #liquidbiopsies🩸

@GarmLise

Published with @TAMedOncol,
@SageJournals

#ColorectalCancer
https://t.co/NsUJunllRi

[Department of Oncology, Aarhus University Hospital @oncaarhus]

PhD-Lunch at @oncaarhus 🍽

Although only a fraction of the 25 PhD-students at the Department seen on the picture @oncaarhus can proudly brag about its diversity with international students from Poland 🇵🇱 India 🇮🇳 Cameroon 🇨🇲 Chile 🇨🇱 Sweden 🇸🇪 and Italy 🇮🇹

#collaborationiskey

[Louise Callesen @L_Callesen]

Published in @TAMedOncol, @SAGEJournals

[Louise Callesen @L_Callesen]

Measurements of circulating DNA can be valuable when selecting and monitoring patients undergoing loco-regional treatment of CRC metastases.

Read our latest systematic review on #colorectalcancer, #cfDNA🧬, #liquidbiopsies🩸

https://t.co/91bNASX63T

@GarmLise, @julian_hamfjord

[Department of Oncology, Aarhus University Hospital @oncaarhus]

I Kræftafdelingens PhD-gruppe bliver der ikke lavet penge - til gengæld går vi ikke ned på break og bling 📽️🕺👩‍🔬👨‍🔬📚
Join us!!
(Del 2 i kommentarfelt)

[Louise Callesen @L_Callesen]

@ACharlemagne3 Congratulation 💪

[Louise Callesen @L_Callesen]

PUBLISHED in @actaoncol today, OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol.

#ctDNA🧬, #liquidbiopsies🩸, #clinicaltrials🔬

https://t.co/gDebTYvJTv

@GarmLise

[Department of Oncology, Aarhus University Hospital @oncaarhus]

The summer has been WAY too long but September is finally here - and that means return of the monthly celebration of a PhD hero. Senior consultant @Alsner is a huge mentor and unreplaceable at @oncaarhus. He is truly our PhD hero - congratulations Jan!